RATIOS
Jagsonpal Pharmaceuticals Ltd.
BSE
Apr 30
225.20
-2.10 ( -0.92%)
Volume
21692
Prev. Close
227.30
Open Price
230.80
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Apr 30
224.96
-2.50 ( -1.10%)
Volume
153359
Prev. Close
227.46
Open Price
226.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Ratio Analysis
for the last 5 years.
ISIN No
|
INE048B01035
|
Market Cap. ( ₹ in Cr. )
|
1494.60
|
P/BV
|
7.58
|
Book Value ( ₹ )
|
29.67
|
BSE Code
|
507789
|
52 Week High/Low ( ₹ )
|
328/110
|
FV/ML
|
2/1
|
P/E(X)
|
66.54
|
NSE Code
|
JAGSNPHARMEQ
|
Book Closure
|
08/01/2025
|
EPS ( ₹ )
|
3.38
|
Div Yield (%)
|
0.89
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 8.49 | 10.20 | 7.48 | 6.51 | 3.00 |
Diluted EPS (Rs.) | 8.46 | 10.20 | 7.48 | 6.51 | 3.00 |
Cash EPS (Rs.) | 9.13 | 10.66 | 8.06 | 6.71 | 3.44 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 70.88 | 60.65 | 46.96 | 43.55 | 39.39 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 70.88 | 60.65 | 49.95 | 46.54 | 42.38 |
Dividend / Share (Rs.) | 5.00 | 5.00 | 4.00 | 1.00 | 0.50 |
Revenue From Operations / Share (Rs.) | 78.94 | 90.36 | 86.30 | 71.74 | 60.53 |
PBDIT / Share (Rs.) | 12.23 | 15.22 | 11.12 | 8.96 | 4.22 |
PBIT / Share (Rs.) | 11.61 | 14.76 | 10.54 | 8.76 | 3.79 |
PBT / Share (Rs.) | 11.30 | 13.29 | 10.43 | 8.35 | 3.59 |
Net Profit / Share (Rs.) | 8.50 | 10.20 | 7.48 | 6.51 | 3.00 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 15.49 | 16.84 | 12.88 | 12.48 | 6.97 |
PBIT Margin (%) | 14.70 | 16.34 | 12.20 | 12.21 | 6.26 |
PBT Margin (%) | 14.31 | 14.70 | 12.08 | 11.63 | 5.93 |
Net Profit Margin (%) | 10.76 | 11.28 | 8.66 | 9.07 | 4.96 |
Return on Networth / Equity (%) | 11.98 | 16.81 | 15.92 | 14.95 | 7.62 |
Return on Capital Employeed (%) | 15.50 | 23.10 | 20.55 | 18.54 | 8.69 |
Return On Assets (%) | 10.34 | 13.70 | 11.62 | 10.38 | 5.35 |
Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.05 | 0.04 |
Asset Turnover Ratio (%) | 1.01 | 1.30 | 1.36 | 1.21 | 1.12 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 10.42 | 5.97 | 3.24 | 2.98 | 2.89 |
Quick Ratio (X) | 9.63 | 5.22 | 2.37 | 2.25 | 2.00 |
Inventory Turnover Ratio (X) | 1.24 | 1.24 | 1.36 | 1.31 | 1.19 |
Dividend Payout Ratio (NP) (%) | 58.31 | 0.00 | 53.50 | 15.35 | 16.64 |
Dividend Payout Ratio (CP) (%) | 54.29 | 0.00 | 49.63 | 14.91 | 14.55 |
Earning Retention Ratio (%) | 41.69 | 0.00 | 46.50 | 84.65 | 83.36 |
Cash Earning Retention Ratio (%) | 45.71 | 0.00 | 50.37 | 85.09 | 85.45 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 39.74 | 96.57 | 102.18 | 21.61 | 21.51 |
Interest Coverage Ratio (Post Tax) (%) | 28.60 | 74.08 | 69.70 | 16.71 | 16.31 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 591.93 | 644.85 | 795.42 | 154.96 | 12.31 |
EV / Net Operating Revenue (X) | 2.84 | 2.72 | 3.52 | 0.82 | 0.07 |
EV / EBITDA (X) | 18.30 | 16.17 | 27.31 | 6.60 | 1.11 |
MarketCap / Net Operating Revenue (X) | 3.54 | 3.21 | 3.63 | 1.11 | 0.28 |
Retention Ratios (%) | 41.68 | 0.00 | 46.49 | 84.64 | 83.35 |
Price / BV (X) | 3.95 | 4.78 | 6.68 | 1.83 | 0.44 |
Price / Net Operating Revenue (X) | 3.54 | 3.21 | 3.63 | 1.11 | 0.28 |
EarningsYield | 0.03 | 0.03 | 0.02 | 0.08 | 0.17 |